Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of an increase in interests in Ordinary shares of GlaxoSmithKline plc purchased at a price of £12.38 per share on 12 April 2011, and ADRs purchased at a price of $39.96 per ADR on 7 April 2011, in respect of the personal holdings of the under-mentioned persons following the re-investment of the dividend paid to shareholders on 7 April 2011.
|
Ordinary shares |
ADRs |
Dr M M Slaoui |
196.67 |
186.37 |
Dr K Belmonte |
|
6.82 |
Mr J M Clarke |
501.50 |
|
Mr M Dunoyer |
2.73 |
|
Mr E J Gray |
283.15 |
|
Mr W C Louv |
|
146.93 |
Dr D Pulman |
|
220.97 |
Mr D S Redfern |
153.31 |
|
Mr J R Stéphenne |
742.05 |
|
Ms C Thomas |
116.05 |
|
Dr P J T Vallance |
69.42 |
|
The Company was advised of this information on 14 April 2011.
This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a) and (c).
V A Whyte
Company Secretary
14 April 2011